| Pasteurella multocida vaccine candidates: A systematic review S Mostaan, A Ghasemzadeh, S Sardari, MA Shokrgozar, GN Brujeni, ... Avicenna journal of medical biotechnology 12 (3), 140, 2020 | 62 | 2020 |
| Identification of different Escherichia coli pathotypes in north and north-west provinces of Iran ST Miri, A Dashti, S Mostaan, F Kazemi, S Bouzari Iranian journal of microbiology 9 (1), 33, 2017 | 43 | 2017 |
| Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea SB Sana Eybpoosh ,Saeid Mostaan ,Mohammad Mehdi Gouya,Hossein Masoumi-Asl ... PLOS ONE 16 (2), 2021 | 22 | 2021 |
| Characterization of antimicrobial susceptibility, extended-spectrum β-lactamase genes and phylogenetic groups of enteropathogenic Escherichia coli isolated from patients with … E Jafari, S Mostaan, S Bouzari Osong Public Health and Research Perspectives 11 (5), 327, 2020 | 12 | 2020 |
| Pasteurella multocida PlpE Protein Polytope as a Potential Subunit Vaccine Candidate S Mostaan, A Ghasemzadeh, MR Asadi Karam, P Ehsani, S Sardari, ... Vector-Borne and Zoonotic Diseases 21 (11), 870-874, 2021 | 10 | 2021 |
| In silico analysis of Pasteurella multocida PlpE protein epitopes as novel subunit vaccine candidates S Mostaan, A Ghasemzadeh, P Ehsani, S Sardari, MA Shokrgozar, ... Iranian biomedical journal 25 (1), 41, 2020 | 9 | 2020 |
| Adverse effects of BCG vaccine 1173 P2 in Iran: A meta-analysis S Mostaan, B Yazdanpanah, R Moukhah, HR Hozouri, M Rostami, ... Advanced biomedical research 5 (1), 99, 2016 | 9 | 2016 |
| A novel combined method for cost–benefit production of DNA ladders S Mostaan, M Ajorloo, H Khanahmad, RA Cohan, ZR Tehrani, M Rezaei, ... Advanced biomedical research 4 (1), 15, 2015 | 7 | 2015 |
| Plpe epitopes of pasteurella multocida fusion protein as novel subunit vaccine candidates S Mostaan, A Ghasemzadeh, P Ehsani, S Sardari, MA Shokrgozar, ... Advanced Biomedical Research 9 (1), 43, 2020 | 2 | 2020 |
| Sequence-subtype association of multi-drug-resistant diarrheagenic Escherichia coli N Farzi, Z Pourramezan, FA Attar, S Mostaan, M Oloomi Iranian Journal of Microbiology 16 (2), 176, 2024 | 1 | 2024 |
| Osong Public Health and Research Perspectives E Jafari, S Mostaan, S Bouzari Osong Public Health and Research Perspectives 11 (5), 327-333, 2020 | | 2020 |
| MOLECULAR STUDY OF ESCHERICHIA COLI COMMON PATHOTYPES IN TEHRAN PROVINCE IN 1389-1390 MH ZAREI, S BOUZARI, S MOSTAAN, ASLH MASOUMI, E MOKARRAMI, ... | | 2017 |
| IDENTIFICATION OF DIFFERENT PATHOTYPES OF ESCHERICHIA COLI IN NORTH AND NORTH-WEST OF IRAN ST MIRI, H NADERI, S BOUZARI, A DASHTI, S MOSTAAN | | 2015 |
| DETERMINATION OF DIFFERENT DIARRHEAGENIC ESCHERICHIA COLI PATHOTYPES IN IRAN: A MOLECULAR EPIDEMIOLOGY STUDY S BOUZARI, MM GOUYA, P OWLIA, ASLH MASOUMI, B ESHRATI, ... | | 2015 |
| DETERMINATION OF INTESTINAL ESCHERICHIA COLI PATHOTYPES FREQUENCY IN ISFAHAN PROVINCE A POURFATHOLLAH, S BOUZARI, A DASHTI, S MOSTAAN, ... | | 2015 |
| Aggregation-based in silico study for better understanding of related membrane interfering analogous of Amphotericin B S Sardari, S Mostaan, P Azerang Microorganisms In Industry And Environment: From Scientific and Industrial …, 2011 | | 2011 |
| Discrepancy Between Interferon Gamma Release Assay and Tuberculin Skin Test for Diagnosis of Latent Tuberculosis Infection in BCG Vaccinated Children S Sayyahfar, A Karimi, SA Fahimzad, M Abolhasani, S Mostaan, ... Pediatric Research 68 (1), 442-443, 2010 | | 2010 |
Saeid BouzariPasteur institute of Iran在 pasteur.ac.ir 的电子邮件经过验证
